![SELECTBIO SELECTBIO](../images/siteimages/SelectBiosciencesLogo.png)
Pathway Illumination for Disease Research - Psychiatric Disorders and Antidepressant Treatment ResponseTuesday, 12 May 2015 at 16:30 ![]() Biomarkers predicting a priori whether an individual patient will respond to the treatment of choice and an early distinction of responders and non-responders during antidepressant therapy can have a significant impact for realizing strategic treatment. |